Evaluation of an automated photometric fibrinogen assay

Blood Coagulation and Fibrinolysis

Volumn 8, Issue 6, 1997, Pages 321-326

  Oosting, J D ^a,b   Hoffmann, J J M L ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b SINT MAARTENSKLINIEK   (Netherlands)

Author keywords

Coagulation; Fibrinogen assays; Fibrinogen degradation products

Indexed keywords

BILIRUBIN; FIBRINOGEN; FIBRINOGEN DEGRADATION PRODUCT; HEMOGLOBIN; HEPARIN; PROTHROMBIN; THROMBIN; TRIACYLGLYCEROL;

ARTICLE; ASSAY; AUTOANALYSIS; BLOOD CLOTTING TIME; CONTROLLED STUDY; CORRELATION FUNCTION; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN TISSUE; PHOTOMETRY; PRIORITY JOURNAL; PROTHROMBIN TIME;

EID: 0030846816     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199709000-00001     Document Type: Article

References (16)

1. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk: results from the PROCAM study in healthy men. Arterioscler Thromb 1994; 14: 54-59. [Erratum, Arterioscler Thromb 1994; 14: 1392.]
2. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; 2: 533-537.
3. Thompson SG, Kienast J, Pyke SDM, Haverkate F, van de Loo JCW, for the European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332: 635-641.
4. Yarnell JWG, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: the Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991; 83: 836-844.
5. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957; 17: 237-246.
6. Chitolie A, Mackie IJ, Grant D, Hamilton JL, Machin SM. Inaccuracy of the "derived" fibrinogen measurement. Blood Coag Fibrinol 1994; 5: 955-957.
7. Hoffmann JJML, Verhappen MAL. Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy. Clin Chem 1988; 34: 2135-2140.
8. Tait RC, Butler A, Singh S. Clinical reliability of the PT-derived fibrinogen assay. Blood Coag Fibrinol 1996; 7: 398.
9. Blombäck B, Blombäck M. Purification of human and bovine fibrinogen. Arkiv Kemi 1956; 10: 415-443.
10. National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices - Second edition; Tentative guideline. NCCLS document EP5-T2 (ISBN 1-56238-145-8). NCCLS, 771 East Lancaster Avenue, Villanova, Pennsylvania 19085, USA, 1992.
11. National Committee for Clinical Laboratory Standards. Preliminary evaluation of quantitative clinical laboratory methods - Second edition; Tentative guideline. NCCLS document EP10-T2 (ISBN 1-56238-196-2). NCCLS, 771 East Lancaster Avenue, Villanova, Pennsylvania 19085, USA, 1993.
12. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983; 21: 709-720.
13. Passing H, Bablok W. Comparison of several regression procedures for method comparison studies and determination of sample sizes. J Clin Chem Clin Biochem 1984; 22: 431-445.
14. Saleem A, Fretz, K. An improved method for plasma fibrinogen based on thrombin time measurement. Clin Chim Acta 1975; 62: 131-136.
15. Jespersen J, Sidelman J. A study of the conditions and accuracy of the thrombin time assay of plasma fibrinogen. Acta Haematol 1982; 67: 2-7.
16. Lurie AA, Gross LF, Rogers WJ. The measurement of fibrinogen by the DuPont aca and Dade methods in patients receiving streptokinase infusions. Am J Clin Pathol 1985; 84: 526-529.